Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $355.0000 (0%) ($0.0000 - $0.0000) on Mon. Feb. 9, 2009. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 15.48% (three month average) | | RSI | 10 | | Latest Price | $355.0000(0%) | | Stocks Behave Similarly | Similar Stock List | | Weekly Trend | CAPR declines -9.5% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability)
IWM(3%) PEJ(3%) XOP(3%) EWI(2%) EWP(2%) | | Factors Impacting CAPR price | CAPR will decline at least -7.74% in a week (0% probabilities).
IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) VWO(0%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -7.74% (StdDev 15.48%) | | Hourly BBV | 0 () | | Intraday Trend | 0% | | | | | |
|
| Resistance Level | $400.8 | | 5 Day Moving Average | $355(0%) | | 10 Day Moving Average | $364.12(-2.5%) | | 20 Day Moving Average | $400.8(-11.43%) | | To recent high | -74.2% | | To recent low | 69% | | Market Cap | $6.993b | | | | | | |
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |